Skip to main content

Axonics, Inc.

AXNXDelisted Nov 15, 2024
Industry
Surgical & Medical Instruments & Apparatus
SEC CIK
0001603756

Axonics, Inc. was delisted on Nov 15, 2024; its insiders filed their last Form 4 on Nov 15, 2024; 233 institutions reported holding it in 13F filings for Q3 2024, worth $3.54B in total; Soros Fund Management was the only superinvestor holding it.

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by Axonics, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
0 filings
Open-market sells
0 filings
Insiders trading
0
Net value
$0
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for Axonics, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for Axonics, Inc.
NameTitleLast reported holdingLast filingFilings, past year
Carrel Michael HDirector0Nov 15, 20240
Cohen Raymond WChief Executive Officer0Nov 15, 20240
Ford Alfred J JrChief Commercial Officer0Nov 15, 20240
Kiernan Jane EDirector0Nov 15, 20240
McNamara RobertDirector0Nov 15, 20240
Demski David MDirector0Nov 15, 20240
snyderman nancy lynn MDDirector0Nov 15, 20240
Noblett KarenChief Medical Officer0Nov 15, 20240
Sama RindaChief Operating Officer0IndirectNov 15, 20240
Woock JohnEVP, Chief Mktg/Strtgy Officer0Nov 15, 20240
Lopez EstebanDirector0Nov 15, 20240
Keese Kari LeighChief Financial Officer0Nov 15, 20240
Dearen Danny L.President & CFO23,777Oct 3, 20230

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Oct 3, 2024 (view filing)Oct 21 dayKeese Kari LeighChief Financial OfficerSSale−2.96K$69.41−$205.5K−6.8%40.4K after2 lots
Feb 2, 2024 (view filing)Jan 312 daysNoblett KarenChief Medical OfficerSSale−11.3K$67.74−$764.6K−24.7%34.4K after
Feb 2, 2024 (view filing)Jan 312 daysWoock JohnEVP, Chief Mktg/Strtgy OfficerSSale−15.9K$67.74−$1.08M−17.0%77.4K after
Feb 2, 2024 (view filing)Jan 312 daysFord Alfred J JrChief Commercial OfficerSSale−16.6K$67.74−$1.13M−27.7%43.5K after
Feb 2, 2024 (view filing)Jan 312 daysKeese Kari LeighChief Financial OfficerSSale−3.49K$67.74−$236.3K−7.5%43.3K after
Feb 2, 2024 (view filing)Jan 312 daysCohen Raymond WChief Executive OfficerSSale−35.2K$67.74−$2.38M−15.7%188.8K after
Jan 10, 2024 (view filing)Jan 82 daysNoblett KarenChief Medical OfficerSSale−16.0K$69.00−$1.10M−46.8%18.2K after10b5-1
Dec 28, 2023 (view filing)Dec 26-282 daysNoblett KarenChief Medical OfficerSSale−8.00K$63.25−$506.0K−19.0%34.2K after2 lots10b5-1
Oct 3, 2023 (view filing)Sep 294 daysDearen Danny L.President & CFOSSale−7.67K$56.87−$436.5K−24.4%23.8K after
Oct 3, 2023 (view filing)Feb 3, 2022607 daysDearen Danny L.President & CFOSSale−18.7K$48.25−$901.5K−32.3%39.2K afterAmended2 lots
Aug 17, 2023 (view filing)Aug 152 daysFord Alfred J JrChief Commercial OfficerSSale−14.8K$62.34−$920.7K−29.9%34.6K after10b5-1
Aug 1, 2023 (view filing)Jul 284 daysFord Alfred J JrChief Commercial OfficerSSale−1.50K$62.01−$93.0K−3.0%49.3K after10b5-1
May 31, 2023 (view filing)May 265 daysDearen Danny L.President & CFOSSale−8.00K$49.47−$395.7K−46.5%9.20K after2 lots10b5-1
Apr 25, 2023 (view filing)Apr 214 daysDearen Danny L.President & CFOSSale−20.0K$60.20−$1.20M−53.8%17.2K after2 lots10b5-1
Apr 24, 2023 (view filing)Apr 204 daysDearen Danny L.President & CFOSSale−2.00K$60.01−$120.1K−7.7%24.0K after10b5-1
Apr 4, 2023 (view filing)Mar 314 daysDearen Danny L.President & CFOSSale−15.0K$55.27−$829.1K−38.5%24.0K after2 lots10b5-1
Feb 23, 2023 (view filing)Feb 212 daysSama RindaChief Operating OfficerSSale−19.9K$56.27−$1.12M−26.3%55.9K after2 lots
Feb 23, 2023 (view filing)Feb 212 daysSama RindaChief Operating OfficerSSale−3.39K$56.53−$191.7K−84.8%608 after
Feb 2, 2023 (view filing)Jan 31-Feb 12 daysSama RindaChief Operating OfficerSSale−18.5K$61.09−$1.13M−19.6%75.8K after4 lots
Feb 2, 2023 (view filing)Jan 31-Feb 12 daysFord Alfred J JrChief Commercial OfficerSSale−9.94K$61.07−$607.0K−16.4%50.8K after4 lots
Feb 2, 2023 (view filing)Jan 31-Feb 12 daysDearen Danny L.President & CFOSSale−13.8K$61.10−$840.6K−36.4%24.0K after4 lots
Feb 2, 2023 (view filing)Jan 31-Feb 12 daysCohen Raymond WChief Executive OfficerSSale−31.0K$61.09−$1.90M−16.2%160.6K after4 lots
Feb 2, 2023 (view filing)Jan 31-Feb 12 daysNoblett KarenChief Medical OfficerSSale−4.63K$61.11−$283.2K−9.9%42.2K after4 lots
Feb 2, 2023 (view filing)Jan 31-Feb 12 daysWoock JohnEVP, Chief Mktg/Strtgy OfficerSSale−11.5K$61.07−$705.3K−15.0%65.3K after4 lots
Jan 19, 2023 (view filing)Jan 172 daysWoock JohnEVP, Chief Mktg/Strtgy OfficerSSale−30.2K$67.34−$2.03M−39.7%46.0K after4 lots
Jan 18, 2023 (view filing)Jan 135 daysCohen Raymond WChief Executive OfficerSSale−40.7K$65.94−$2.69M−27.2%108.9K after2 lots
Jan 18, 2023 (view filing)Jan 135 daysFord Alfred J JrChief Commercial OfficerSSale−36.0K$66.40−$2.39M−49.5%36.8K after3 lots
Dec 15, 2022 (view filing)Dec 132 daysLopez EstebanDirectorSSale−2.00K$67.42−$134.8K−35.7%3.60K after
Sep 20, 2022 (view filing)Sep 128 daysLateNoblett KarenChief Medical OfficerSSale−32.5K$78.16−$2.54M−50.7%31.6K after
Sep 15, 2022 (view filing)Sep 132 daysDearen Danny L.See RemarksSSale−656$75.60−$49.6K−8.0%7.50K after
Sep 12, 2022 (view filing)Sep 84 daysWoock JohnChief Marketing OfficerSSale−7.50K$75.01−$562.5K−14.0%46.0K after2 lots
Sep 9, 2022 (view filing)Sep 72 daysNoblett KarenChief Medical OfficerSSale−10.5K$71.53−$747.8K−24.9%31.6K after
Aug 26, 2022 (view filing)Aug 251 dayWoock JohnChief Marketing OfficerSSale−7.50K$72.95−$547.1K−14.0%46.0K after2 lots
Aug 15, 2022 (view filing)Aug 114 daysDearen Danny L.See RemarksSSale−50.0K$70.89−$3.54M−86.0%8.16K after3 lots
Aug 12, 2022 (view filing)Aug 102 daysWoock JohnChief Marketing OfficerSSale−15.0K$69.71−$1.05M−21.9%53.5K after2 lots
Aug 12, 2022 (view filing)Aug 102 daysSama RindaChief Operating OfficerSSale−33.9K$69.56−$2.35M−38.2%54.7K after2 lots
Aug 10, 2022 (view filing)Aug 82 daysCohen Raymond WChief Executive OfficerSSale−44.0K$70.44−$3.10M−22.7%149.6K after4 lots
Aug 9, 2022 (view filing)Aug 54 daysSama RindaChief Operating OfficerSSale−13.1K$70.88−$928.1K−19.3%54.7K after2 lots
Jul 7, 2022 (view filing)Apr 1-Jul 597 daysLateKiernan Jane EDirectorSSale−7.00K$60.68−$424.7K−32.2%14.8K after2 lots
Mar 31, 2022 (view filing)Mar 292 daysCohen Raymond WChief Executive OfficerSSale−50.0K$60.00−$3.00M−20.5%193.6K after
Mar 31, 2022 (view filing)Mar 292 daysKiernan Jane EDirectorSSale−5.25K$60.50−$317.6K−40.9%7.59K after2 lots
Mar 22, 2022 (view filing)Mar 184 daysNoblett KarenChief Medical OfficerSSale−13.5K$57.23−$774.4K−24.3%42.1K after
Mar 16, 2022 (view filing)Mar 142 daysCohen Raymond WChief Executive OfficerSSale−50.0K$52.82−$2.64M−17.0%243.6K after5 lots
Mar 3, 2022 (view filing)Mar 12 daysDearen Danny L.See RemarksSSale−19.9K$57.70−$1.15M−49.1%20.7K after3 lots
Mar 1, 2022 (view filing)Feb 254 daysDearen Danny L.See RemarksSSale−10.0K$57.00−$570.0K−26.2%28.2K after
Feb 3, 2022 (view filing)Feb 12 daysDearen Danny L.President & CFOSSale−20.0K$48.71−$974.1K−66.7%10.0K afterAmended4 lots
Feb 3, 2022 (view filing)Feb 3Same dayNoblett KarenChief Medical OfficerSSale−6.68K$48.25−$322.4K−10.7%55.6K after2 lots
Feb 3, 2022 (view filing)Feb 3Same daySama RindaChief Operating OfficerSSale−11.9K$48.25−$573.3K−14.9%67.8K after2 lots
Feb 3, 2022 (view filing)Feb 3Same dayWoock JohnChief Marketing OfficerSSale−6.25K$48.25−$301.6K−9.3%61.0K after2 lots
Feb 3, 2022 (view filing)Feb 3Same dayFord Alfred J JrChief Commercial OfficerSSale−9.27K$48.25−$447.1K−20.1%36.8K after2 lots